Comparison of the perioperative effect and postoperative recovery of patients undergoing laparoscopic bariatric surgery based on low-opioid general anesthesia with ultrasound-guided erector spinae plane block,ESPB versus Transversus abdominis plane block,TAP .

Ultrasound-guided erector spinae plane block,ESPB on perioperative effect and postoperative recovery of patients undergoing laparoscopic sleeve gastrectomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076676

Enrollment

Unknown

Registered

2023-10-16

Start date

2023-10-16

Completion date

Unknown

Last updated

2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing bariatric surgery

Interventions

Group E:Before low-opioid general anesthesia, perform erector spinae plane block under ultrasound guidance(ropivacaine) and local anesthesia, if there are no anesthesia related complications then pe

Group C:Before low-opioid general anesthesia, perform transversus abdominis plane block under ultrasound guidance(ropivacaine) and local anesthesia, if there are no anesthesia related complications

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1.1) diagnosed with obesity(BMI=30) , plan to undergo laparoscopic bariatric surgery (1.2)18=Age=60,Gender unlimited; (1.3)Clearly understand, voluntarily participate in the study, and have their informed consent form signed by themselves (1.4)ASA ?~?

Exclusion criteria

Exclusion criteria: (2.1)Concomitant severe cardiovascular, pulmonary, and cerebral diseases, such as uncontrolled hypertension, coronary heart disease, congenital heart disease, valve disease, intracranial vascular malformations, asthma , COPD , etc; (2.2)Contraindications to pulmonary atelectasis (such as bullous pulmonary disease, unstable hemodynamics; (2.3)Have a history of chest surgery; (2.4)Communication barriers, inability to cooperate with researchers, such as language comprehension disorders, mental illnesses, etc; (2.5) Experienced heart or brain infarction within six months; (2.6)Acute, systemic infectious diseases, fever above moderate level; (2.7)Severe coagulation dysfunction; (2.8)Pregnant women; (2.9)Participants who participated in other clinical trials within 3 months prior to being selected for the study; (2.10)Other situations that researchers believe are not suitable for inclusion.

Design outcomes

Primary

Measure	Time frame
The situation of postoperative pain(NRS);The situation of PONV;	—

Secondary

Measure	Time frame
Intraoperative drug usage;Intraoperative patient situation;Postoperative recovery of patients;	—

Countries

China

Contacts

Public ContactKe Wei

Anesthesiology Department of the First Affiliated Hospital of Chongqing Medical University

wk202448@hospital-cqmu.com+86 159 0236 0621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026